Copyright
©2013 Baishideng Publishing Group Co.
World J Gastrointest Endosc. Aug 16, 2013; 5(8): 379-390
Published online Aug 16, 2013. doi: 10.4253/wjge.v5.i8.379
Published online Aug 16, 2013. doi: 10.4253/wjge.v5.i8.379
Ref. | n | BT-dose U | Initial symptomatic response | Injection rate | Long-term symptomatic response | Follow up (mo) |
Wehrmann et al[19] | 20 | 100 | 80% | 2.5 | 70% | 24 |
Annese et al[20] | 36 | 100 | 90% | 0 | 78% | 6 |
Pasricha et al[28] | 31 | 80 | 90% | 1.6 | 68% | 12 |
Fishman et al[31] | 60 | 80 | 70% | 1.3 | 36% | 12 |
Annese et al[32] | 38 | 100 | 82% | 1 | 68% | 24 |
Gordon et al[100] | 16 | 80 | 75% | 1.25 | 58% | 7 |
Cuillière et al[101] | 55 | 80 | 85% | 1.2 | 60% | 6 |
Vaezi et al[102] | 22 | 100 | 64% | 1.1 | 32% | 12 |
- Citation: Müller M, Eckardt AJ, Wehrmann T. Endoscopic approach to achalasia. World J Gastrointest Endosc 2013; 5(8): 379-390
- URL: https://www.wjgnet.com/1948-5190/full/v5/i8/379.htm
- DOI: https://dx.doi.org/10.4253/wjge.v5.i8.379